Stock EVFM EVOFEM BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Evofem Biosciences, Inc.

Equities

EVFM

US30048L3024

Delayed OTC Markets
Other stock markets
 09:30:28 2024-04-29 EDT 		5-day change 1st Jan Change
0.0165 USD -1.49% Intraday chart for Evofem Biosciences, Inc. +3.77% -74.22%
03-27 Evofem Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-27 Evofem Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Evolution of the average Target Price on Evofem Biosciences, Inc.

Price target over the last 5 years

History of analyst recommendation changes

33c9c7de836.agDSXnPIyMEvyk8HsSPLF__b53CZIFHfFyxDaUEayg0.A0-cKCKxrq5puxhP8nu9TZri0jv1EyuXZRQyLDhgpzlccuEXR_yRuFeNLA~d97c537b3d0e8dec9085c43ac488921b

Analyst Recommendations on Evofem Biosciences, Inc.

Laidlaw Downgrades Evofem Biosciences to Hold From Buy MT
Stifel Downgrades Evofem Biosciences to Hold From Buy, Adjusts Price Target to $0.50 From $3 MT
HC Wainwright Adjusts Price Target on Evofem Biosciences to $4 From $2, Reiterates Buy Rating MT
Morgan Stanley Adjusts Price Target for Evofem Biosciences to $0.75 From $2, Maintains Underweight Rating MT
Laidlaw & Co. Initiates Evofem Biosciences at Buy with $3.50 Price Target MT
Piper Sandler Adjusts Price Target on Evofem Biosciences to $2 From $30, Reiterates Overweight Rating MT
Wall Street Set for Gains as China Rate Cut Boosts Sentiment MT
Morgan Stanley Lowers Evofem Biosciences Price Target to $2 From $8.55, Maintains Underweight Rating MT
EVOFEM BIOSCIENCES : HC Wainwright Adjusts Evofem Biosciences' Price Target to $2.50 from $4, Keeps Buy Rating MT
EVOFEM BIOSCIENCES : Morgan Stanley Downgrades Evofem Biosciences to Underweight Rating From Equal-Weight, Lowers PT to $0.80 From $1 MT
EVOFEM BIOSCIENCES : Morgan Stanley Adjusts Price Target on Evofem Biosciences to $1 From $3, Maintains Equal-Weight Rating MT
EVOFEM BIOSCIENCES : HC Wainwright Adjusts Price Target on Evofem Biosciences to $4 From $7, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.0168
Average target price
-

Consensus detail

Consensus revision (last 18 months)

Analysts covering Evofem Biosciences, Inc.

Laidlaw & Co.
Stifel Nicolaus
HC Wainwright
Morgan Stanley
Piper Sandler

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. EVFM Stock
  4. Consensus Evofem Biosciences, Inc.